Pengaruh penggunaan AD-Pharm Hypertension Mobile Health Application terhadap tingkat kepatuhan minum obat pasien hipertensi di Puskesmas Kota Yogyakarta

Authors

  • Novianti Wigka Pawestri Program Studi Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta
  • Ginanjar Zukhruf Saputri Program Studi Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta
  • Ana Hidayati Program Studi Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta
  • Lalu Muhammad Irham Program Studi Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta
  • Putri Hanisari Puskesmas Umbul Harjo 1, Yogyakarta
  • Yuni S Puskesmas Jetis, Yogyakarta
  • Tiwi Galuh Puskesmas Mantrijeron, Yogyakarta
  • Sany Sany Puskesmas Gedongtengen, Yogyakarta

DOI:

https://doi.org/10.21111/pharmasipha.v9i1.13123

Abstract

The prevalence of hypertension in Indonesia is still quite high. One of the causes of the high incidence of hypertension is patient’s nonadherence in their treatment, such as forgetting to take medication. The patient's medication adherence determines the success of hypertension therapy. AD-Pharm Hypertension Mobile Health Application contains several features, one of which is a reminder to remind patients to take medication. The purpose of this study was to determine the effect of the AD-Pharm Hypertension Mobile Health Application on the level of medication adherence of hypertension patients in 4 public health centers in Yogyakarta.  This research method is a quasi-experimental pre-post design with a control group. The sampling technique was consecutive sampling involving 100 respondents, of which 50 respondents were the control group and 50 were the intervention group. The intervention that is given is AD-Pharm hypertension mobile health application. Data were collected using the MARS-5 questionnaire which were analyzed using Mann Whitney test and the Wilcoxon test. The results of the analysis showed that there was a significant difference (p=0.001) of medication adherence between the pre and post-test of the intervention group from 23.96±1.525 to 24.46±1. While in the control group there was no significant difference (p=0.059), from 24.04±1.142 (pre-test) to 24.16±0.976 (post-test). Based on the results of this study, it can be concluded that there is a significant effect on the use of AD-Pharm Hypertension Mobile Health Application on the level of medication adherence of hypertension patients.

Downloads

Published

2025-03-31

Issue

Vol. 9 No. 1 (2025): Maret

Section

Articles

License

Copyright (c) 2025 Novianti Wigka Pawestri, Ginanjar Zukhruf Saputri, Ana Hidayati, Lalu Muhammad Irham, Putri Hanisari, Yuni S, Tiwi Galuh, Sany

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this Journal agree to the following terms:

  1. Author retain copyright and grant the journal right of first publication with the work simultaneously licensed under a creative commons attribution license that allow others to share the work within an acknowledgement of the work’s authorship and initial publication of this journal.
  2. Authors are able to enter into separate, additional contractual arrangement for the non-exclusive distribution of the journal’s published version of the work (e.g. acknowledgement of its initial publication in this journal).
  3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published works.